These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31471448)

  • 1. Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review.
    Marin M; Leung J; Gershon AA
    Pediatrics; 2019 Sep; 144(3):. PubMed ID: 31471448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine Oka Varicella Meningitis in Two Adolescents.
    Harrington WE; Mató S; Burroughs L; Carpenter PA; Gershon A; Schmid DS; Englund JA
    Pediatrics; 2019 Dec; 144(6):. PubMed ID: 31776194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
    Wu Q; Rivailler P; Xu S; Xu W
    J Virol; 2019 May; 93(9):. PubMed ID: 30728261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus.
    Heusel EH; Grose C
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
    Tsolia M; Gershon AA; Steinberg SP; Gelb L
    J Pediatr; 1990 Feb; 116(2):184-9. PubMed ID: 2153790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated vaccine-induced varicella infection in a kidney transplant recipient.
    Berman MA; Rupp RE
    Am J Transplant; 2023 Nov; 23(11):1806-1810. PubMed ID: 37286085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for herpes zoster vaccination of immunocompromised patients.
    Cohen JI
    J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S237-41. PubMed ID: 18419403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
    Alexander KE; Tong PL; Macartney K; Beresford R; Sheppeard V; Gupta M
    Vaccine; 2018 Jun; 36(27):3890-3893. PubMed ID: 29807711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka.
    Umit Z; Sahbudak Bal Z; Zeytinoglu A; Gulbahar Aydogan T; Bag O; Guner Ozenen G; Ozkinay F; Kurugol Z
    Hum Vaccin Immunother; 2021 Nov; 17(11):4190-4193. PubMed ID: 34643479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella and herpes zoster vaccine development: lessons learned.
    Warren-Gash C; Forbes H; Breuer J
    Expert Rev Vaccines; 2017 Dec; 16(12):1191-1201. PubMed ID: 29047317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
    Uebe B; Sauerbrei A; Burdach S; Horneff G
    Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A booster administration of the OKA/SK strain causes fatal disseminated varicella in an immunocompetent child.
    Kang HM; Kang KR; Kim YJ; Kang JH; Lee SY
    J Med Virol; 2023 Sep; 95(9):e29108. PubMed ID: 37715715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts.
    LaRussa P; Steinberg S; Meurice F; Gershon A
    J Infect Dis; 1997 Oct; 176(4):1072-5. PubMed ID: 9333170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-Strain Varicella Virus Transmitted to a Term Infant Following Maternal Postpartum Vaccination.
    Saringkarisate K; Len KA; Melish ME; Prothero BK; Ching N
    J Pediatric Infect Dis Soc; 2022 Oct; 11(10):452-453. PubMed ID: 35751631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular aspects of the live attenuated Oka varicella vaccine.
    Quinlivan M; Breuer J
    Rev Med Virol; 2014 Jul; 24(4):254-73. PubMed ID: 24687808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus vaccine, successes and difficulties.
    Sarkadi J
    Acta Microbiol Immunol Hung; 2013 Dec; 60(4):379-96. PubMed ID: 24292083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.